| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/30/1993 | CA2131154A1 Antiviral peptides |
| 09/30/1993 | CA2130836A1 Further indole derivatives with antiviral activity |
| 09/30/1993 | CA2130196A1 Benzodiazepine derivatives |
| 09/30/1993 | CA2130195A1 Benzodiazepine derivatives, compositions containing them and their use in therapy |
| 09/30/1993 | CA2124353A1 Sustained release composition and method utilizing xanthan gum and an active ingredient |
| 09/30/1993 | CA2120703A1 Novel vitamin d analogues |
| 09/29/1993 | EP0563024A1 Percutaneous salve preparation in the form of an adhesive tape |
| 09/29/1993 | EP0563001A1 Imidazole compounds, their preparation and use |
| 09/29/1993 | EP0562956A1 Naphtylalkylamines, process for their preparation and pharmaceutical compositions containing them |
| 09/29/1993 | EP0562936A1 Imidazolines N-substituted by a biphenylmethyl group, their preparation, the pharmaceutical compositions containing them |
| 09/29/1993 | EP0562855A1 Carbapenem compounds as antibiotics |
| 09/29/1993 | EP0562853A1 29-Demethoxyrapamycin for inducing immunosuppression |
| 09/29/1993 | EP0562849A2 Steroid derivatives |
| 09/29/1993 | EP0562833A1 Anti-ulcer pyridyloxy derivatives, their preparation and uses |
| 09/29/1993 | EP0562832A1 Indole and indazole derivatives, for the treatment and prophylaxis of cerebral disorders, their preparation and their use |
| 09/29/1993 | EP0562734A1 Anti-tumour compounds containing quinazoline and tetrazole rings |
| 09/29/1993 | EP0562705A1 Use of L-deprenyl for the manufacture of a medicament for the treatment of Cushing's Disease |
| 09/29/1993 | EP0562643A2 7-Substituted-hept-6-enoic and -heptanoic acids and derivatives thereof |
| 09/29/1993 | EP0562641A1 Dehydrated liposomes |
| 09/29/1993 | EP0562583A1 Alkylene diammonium diclavulanate derivatives, process for their preparation and for their use |
| 09/29/1993 | EP0562512A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines |
| 09/29/1993 | EP0562439A1 Triazolopyridazines as antioasthmatics |
| 09/29/1993 | EP0562306A1 Pharmaceutical composition having antiviral and antibacterial activity |
| 09/29/1993 | EP0562261A2 Sulphonylbenzyl substituted imidazoles |
| 09/29/1993 | EP0562083A1 Vanadyl complexes of hydroxamate chelators and pharmaceutical compositions comprising them |
| 09/29/1993 | EP0562049A1 Novel 4-arylpiperazines and 4-arylpiperidines |
| 09/29/1993 | EP0562042A1 Quinoline, naphthyridine and pyridobenzoxazine derivatives |
| 09/29/1993 | EP0562020A1 A vaccine against cholesterol to prevent hypercholesterolemia and atherosclerosis |
| 09/29/1993 | EP0562009A1 ENANTIOMERICALLY PURE $g(b)-D-(-)-DIOXOLANE-NUCLEOSIDES |
| 09/29/1993 | EP0562006A1 Homo-prostaglandin derivatives as ocular hypotensives |
| 09/29/1993 | EP0561989A1 Compounds that inhibit complement and/or suppress immune activity |
| 09/29/1993 | EP0561979A1 Use of angiotensin ii antagonists in the treatment of angina pectoris |
| 09/29/1993 | EP0561977A1 Use of angiotensin ii receptor antagonists in the treatment of hemorragic stroke |
| 09/29/1993 | EP0561973A1 Antiallergic compounds |
| 09/29/1993 | EP0561965A1 Enhancement of musculature in animals |
| 09/29/1993 | EP0561948A1 Phosphonic acid derivatives useful as antiinflammatory agents. |
| 09/29/1993 | EP0561939A1 Use of angiotensin ii receptor antagonists in the treatment of diabetic nephropathy |
| 09/29/1993 | EP0561913A1 Use of pyridine derivatives in the treatment of ocular hypertension |
| 09/29/1993 | EP0561910A1 Pharmaceuticals |
| 09/29/1993 | EP0561905A1 Use of angiotensin ii receptor antagonists in the treatment of macular degeneration |
| 09/29/1993 | EP0561901A1 Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy |
| 09/29/1993 | EP0561896A1 Use of angiotensn ii receptor antagonists for the preparation of a medicament for improving cognitive function |
| 09/29/1993 | EP0561895A1 Use of angiotensin ii receptor antagonists in the prevention of restinosis |
| 09/29/1993 | EP0561883A1 Polymorphs of crystalline mupirocin |
| 09/29/1993 | EP0561878A1 Use of angiotensin ii antagonist in the treatment of infarction |
| 09/29/1993 | EP0561866A1 Lyophilized amino acid compositions containing glutamine. |
| 09/29/1993 | EP0561861A1 A process for the preparation of diltiazem. |
| 09/29/1993 | EP0561850A1 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds useful as antibacterial agents |
| 09/29/1993 | EP0561772A1 A new pharmaceutical use of fusidic acid and derivatives thereof |
| 09/29/1993 | EP0523150A4 Device and method for enhanced administration of physostigmine |
| 09/29/1993 | EP0443028B1 Non-injection carcinostatic agent for suppressing occurrence of inflammation due to 5-fluorouracil and method for curing cancer |
| 09/29/1993 | EP0428520B1 Antimicrobial composition with long-term activity |
| 09/29/1993 | EP0387252B1 Lubricant composition for rheumatism |
| 09/29/1993 | CN1076696A Pharmaceutical compounds |
| 09/29/1993 | CN1076695A Baccatine iii derivatives |
| 09/29/1993 | CN1076691A Sulfonamido-and sulfonamidocarbonyl-pyridin-2-carbonsaureamide as well as pyridin-n-oxide thereof |
| 09/29/1993 | CN1076690A Sulfonamidocarboxamides |
| 09/29/1993 | CN1076689A N,n'-substituted imidodicarbonimidic diamides derived from hydroxylamines |
| 09/29/1993 | CN1076615A Low side-effect compound gentamicin preparation |
| 09/29/1993 | CN1076614A Liposomal itraconazole formulations |
| 09/29/1993 | CN1076613A Elemene emulsion injection and its preparing process |
| 09/29/1993 | CN1022248C Novel 2'-halomethylidene, uridine and guanosine drivatives |
| 09/29/1993 | CN1022246C Method of preparation 1-acyl-3-(4-(2-pyrimidyl)-1-piperazyl) propane |
| 09/29/1993 | CN1022245C Process of preparing |5(6)(1H-azole-1-ylmethyl) benzimidazole¨ carbamates |
| 09/29/1993 | CN1022244C Tetrazole excitatory amino acid receptor antagonists |
| 09/29/1993 | CN1022243C Method of preparation of indole derivatives |
| 09/29/1993 | CN1022241C Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides |
| 09/29/1993 | CA2092770A1 Carboxylic acid esters of 2-amino-7-/(1,3-dihydroxy-2-propoxy)methyl/purine, their preparation and their use |
| 09/28/1993 | US5248810 Halogenated olefins, processes for their preparation and their use as pesticides |
| 09/28/1993 | US5248807 Triterpene derivatives |
| 09/28/1993 | US5248785 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood |
| 09/28/1993 | US5248776 Process for enantiomerically pure β-L-1,3-oxathiolane nucleosides |
| 09/28/1993 | US5248771 Diagnosis and treatment of brain disorders caused by herpes herpes virus |
| 09/28/1993 | US5248699 Hydrochloride salt, antidepressant, anorectic |
| 09/28/1993 | US5248697 For treatment of radiation associated oxidative damage in tissue |
| 09/28/1993 | US5248696 Composition and method for treating tumors |
| 09/28/1993 | US5248695 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in animal feeds |
| 09/28/1993 | US5248693 Acetylene compounds and pharmaceutical compositions and methods of using the same |
| 09/28/1993 | US5248691 Furanoindolines |
| 09/28/1993 | US5248690 Method for treatment of neurodegenerative diseases |
| 09/28/1993 | US5248688 Mixtures of amino acids |
| 09/28/1993 | US5248685 5-lipoxygenase inhibitor |
| 09/28/1993 | US5248684 Certain 2-oxo-quinoline carboxylates or corresponding carboxamides useful as anti-emetics and suppressants of migraine |
| 09/28/1993 | US5248681 Antiinflammatory agents |
| 09/28/1993 | US5248680 Zwitterionic compounds and their n-halo derivatives for use in the treatment of clinical conditions |
| 09/28/1993 | US5248678 Methods for increasing arousal and alertness and for the amelioration of comatose states |
| 09/28/1993 | US5248676 Estradiol percutaneous administration preparations |
| 09/28/1993 | US5248674 Percutaneous administration of 3'-azide'-deoxythymidine |
| 09/28/1993 | US5248672 Polysubstituted benzimidazole nucleosides as antiviral agents |
| 09/28/1993 | US5248670 Phosphorothioate internucleotide bonds |
| 09/28/1993 | US5248669 Inhibition of anoxia or hypoxia-induced, endothelium-mediated vasospasm with avermectins |
| 09/28/1993 | US5248668 Use of purpurogallin and glycosides thereof in treating ischemia in mammals |
| 09/28/1993 | US5248507 Hypertonic isochloremic formulation for circulatory shock |
| 09/28/1993 | US5248505 Administering antidiarrheal and antiflatulence composition |
| 09/28/1993 | US5248504 Method of treatment for nasal and sinus dysfunction |
| 09/28/1993 | US5248494 Applying in a carrier to skins |
| 09/28/1993 | US5248493 Pharmaceutical composition |
| 09/28/1993 | CA2092766A1 Steroid derivatives |
| 09/28/1993 | CA2092729A1 Method for inducing immunosuppression |
| 09/28/1993 | CA1322556C2 Fumaric acid derivatives, process for the production thereof and pharmaceutical compositions containing same |